静脈内輸液ポンプの市場規模、シェア、成長分析：製品別、適応疾患別、最終用途別、地域別 - 産業予測 2025～2032年

静脈内輸液ポンプ 2023年の市場規模は162億4,000万米ドルで、2024年の175億4,000万米ドルから2032年には324億6,000万米ドルに拡大し、予測期間（2025-2032年）のCAGRは8.0％で成長する見通しです。

世界の静脈内輸液ポンプ市場は、慢性疾患の増加、高齢化、医療技術の進歩などを背景に、大幅な成長が見込まれています。輸液ポンプは、輸液や薬剤を血流に直接正確に送り込むことができるため、さまざまなヘルスケア現場で不可欠な機器です。継続的な輸液療法を必要とする在宅医療サービスの需要の高まりや、臨床環境における正確な薬剤投与の必要性が、市場の成長をさらに促進しています。さらに、投薬ミスを最小限に抑え、患者の安全性を向上させることに重点を置いていることも、この市場を前進させています。今後は、ユーザーフレンドリーなコネクテッドデバイスの導入、データ駆動型テクノロジー、患者中心の設計が、ヘルスケアプロバイダーと患者双方の進化するニーズに応える上で重要になるでしょう。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

静脈内輸液ポンプ市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 容積式輸液ポンプ
• インスリン注入ポンプ
• シリンジ輸液ポンプ
• 経腸輸液ポンプ
• 携帯型輸液ポンプ

静脈内輸液ポンプ市場規模：適応疾患別& CAGR（2025-2032）

• 市場概要
• 糖尿病
• 化学療法
• 血液内科
• その他

静脈内輸液ポンプ市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院
• 老人ホーム
• 在宅ケア

静脈内輸液ポンプ市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• B. Braun Melsungen AG（Germany）
• Baxter International Inc.（USA）
• Becton, Dickinson and Company（USA）
• ICU Medical, Inc.（USA）
• Medtronic PLC（Ireland）
• Fresenius Kabi AG（Germany）
• Smiths Group plc（UK）
• Terumo Corporation（Japan）
• Mindray Medical International Limited（China）
• Moog Inc.（USA）
• Zyno Medical（USA）
• Advanced Instrumentations（USA）
• Micrel Medical Devices（Greece）
• Plenum Tech（USA）
• Sino Medical-Device Technology Co., Ltd.（China）
• Insulet Corporation（USA）
• Tandem Diabetes Care, Inc.（USA）
• vTitan Corporation Pvt. Ltd.（India）
• Nipro Corporation（Japan）

結論と提言

Intravenous Infusion Pump Market size was valued at USD 16.24 billion in 2023 and is poised to grow from USD 17.54 billion in 2024 to USD 32.46 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The global intravenous (IV) infusion pump market is poised for substantial growth, driven by an increase in chronic diseases, an aging population, and advancements in medical technology. These essential devices enable the precise delivery of fluids and medications directly into the bloodstream, making them vital in various healthcare settings. The rising demand for home healthcare services requiring continuous infusion therapies and the imperative for accurate drug administration in clinical environments further enhance market growth. Additionally, the focus on minimizing medication errors and improving patient safety is propelling this market forward. Moving ahead, the introduction of user-friendly, connected devices, alongside data-driven technologies and patient-centric designs, will be crucial in meeting the evolving needs of healthcare providers and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Intravenous Infusion Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Intravenous Infusion Pump Market Segments Analysis

Global Intravenous Infusion Pump Market is segmented by Product, Disease Indication, End-use and region. Based on Product, the market is segmented into Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps and Ambulatory Infusion Pumps. Based on Disease Indication, the market is segmented into Diabetes, Chemotherapy, Hematology and Others. Based on End-use, the market is segmented into Hospitals, Nursing Homes and Home Care. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Intravenous Infusion Pump Market

The rising incidence of chronic diseases like cancer, diabetes, and cardiovascular ailments, along with the aging global population, significantly propels the demand for intravenous (IV) infusion pumps. These vital devices play a crucial role in delivering medications, fluids, and nutrients with precision to patients undergoing prolonged treatments, thereby enhancing disease management and promoting better health outcomes. As healthcare systems increasingly prioritize accurate and efficient treatment methods, the necessity for advanced IV infusion pumps continues to grow, reflecting the broader trends in patient care and chronic disease management on a worldwide scale.

Restraints in the Intravenous Infusion Pump Market

The intravenous infusion pump market faces significant restraints due to the high costs associated with the purchase and maintenance of advanced models. The initial financial investment, combined with ongoing expenses for calibration, regular maintenance, and staff training, can create substantial strains on healthcare budgets. This economic burden poses a significant challenge for healthcare facilities, especially those operating in resource-constrained environments or regions with limited financial resources. As a result, the affordability and accessibility of these critical devices may be compromised, ultimately impacting the delivery of quality healthcare in various settings.

Market Trends of the Intravenous Infusion Pump Market

The intravenous infusion pump market is witnessing a strong shift towards smart and connected devices, reflecting broader digital healthcare trends. These innovative infusion pumps are equipped with advanced features such as dose calculation assistance, integration with electronic health records (EHR), and real-time monitoring, significantly enhancing patient safety and operational efficiency. The demand for such technology-driven solutions is rising as healthcare providers seek to minimize medication errors and improve workflow processes. Additionally, the trend of remote monitoring capabilities allows for timely adjustments in patient care, underscoring the increasing importance of connectivity and automation in modern healthcare environments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Intravenous Infusion Pump Market Size by Product & CAGR (2025-2032)

• Market Overview
• Volumetric Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Enteral Infusion Pumps
• Ambulatory Infusion Pumps

Global Intravenous Infusion Pump Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Diabetes
• Chemotherapy
• Hematology
• Others

Global Intravenous Infusion Pump Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Nursing Homes
• Home Care

Global Intravenous Infusion Pump Market Size & CAGR (2025-2032)

• North America (Product, Disease Indication, End-use)
  • US
  • Canada
• Europe (Product, Disease Indication, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Disease Indication, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Disease Indication, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Disease Indication, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moog Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zyno Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Instrumentations (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micrel Medical Devices (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Plenum Tech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Medical-Device Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• vTitan Corporation Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations